Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

LEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).

The trial aims to assess the safety and efficacy of tralokinumab 300mg administered biweekly as a single agent.

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Apogee Therapeutics, Inc. (NASDAQ:APGE) is one of the 10 Stocks Crash Hard Alongside Wall Street. Apogee Therapeutics fell by ...

A new study published in the Journal of American Medical Association showed that Guselkumab was highly effective and durable ...

Equities in Toronto ran out of steam Tuesday, amid uncertainty over U.S. President Trump's timing and severity of tariffs ...

Learn how cyber security resilience protects Pakistan against evolving cyber threats and how Wateen's CSaaS defends national ...

New data reveals sponsors risk wasting billions by designing overly complex trials and repeatedly recruiting from oversaturated investigator sites Boston, US. 9 July, 2025. Dr. Gen Li, CEO of Phesi, a ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

To add FT coverage as predictors, we ran more than 40 years of FT articles through a well-known topic model, named Latent Dirichlet Allocation. This gives us a clear picture of what our journalists ...